ArticleThe Journal of antimicrobial chemotherapy2016

Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection.

Eugénie Bassères et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.